While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

WisdomTree U.S. SmallCap Dividend Fund offers a 2.8% yield but underperforms peers, with a sector allocation impacting growth potential. Learn more on DES stock here.

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where UnitedHealth Group Incorporated ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price target ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Sagility acquires BroadPath Healthcare Solutions, adding 30+ clients and enhancing operations with Bhive platform and ...

Joe McCarthy from Elston and David Wilson from First Sentier run the ruler over your most-tipped growth stocks for 2025 ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.